Class IITerminatedD-1011-2020
Drug recall · March 18, 2020
Morphine Sulfate recall
Why: Lack Of Processing Controls
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Morphine Sulfate (MITIGO), 5 mg/mL intrathecal, 40 mL per syringe. Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901
- Lots / codes
Lot 02242020@14
- Quantity
- 1 40 ml syringe
- Company
- Redline Pharmacy Solutions, Hastings, NE
- Distribution
- Sold to patients in Nebraska
- Initiated
- February 24, 2020 · Voluntary: Firm initiated
- Classified
- March 12, 2020
- Reported
- March 18, 2020
- Ended
- March 31, 2022
- How notified
- Telephone
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Class IITerminatedMar 18, 2020Acetylcysteine Ophthalmic 10% SolutionRedline Pharmacy Solutions · D-1006-2020Class IITerminatedMar 18, 2020Morphine SulfateRedline Pharmacy Solutions · D-1007-2020Class IITerminatedMar 18, 2020DaptomycinRedline Pharmacy Solutions · D-1008-2020Class IITerminatedMar 18, 2020Ertapenem in 100ML 0.9% NACL 1GM InjectableRedline Pharmacy Solutions · D-1009-2020Class IITerminatedMar 18, 2020Vancomycin 900MG in 100ML 0.9% NACL InjectableRedline Pharmacy Solutions · D-1010-2020
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Morphine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.